Tapering subcutaneous methotrexate causes more disease flares compared with tapering oral administration in established rheumatoid arthritis patients.
Agnes E M LooijenElise van MulligenAnnette H M van der Helm-van MilPascal H P de JongPublished in: Rheumatology (Oxford, England) (2022)